​

Avadel Pharmaceuticals (AVDL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AVDL Stock Forecast

Avadel Pharmaceuticals (AVDL) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $23.33, with a high of $30.00 and a low of $19.00. This represents a 190.54% increase from the last price of $8.03.

$5 $10 $15 $20 $25 $30 High: $30 Avg: $23.33 Low: $19 Last Closed Price: $8.03

AVDL Stock Rating

Avadel Pharmaceuticals stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 12 Strong Sell Sell Hold Buy Strong Buy

AVDL Price Target Upside V Benchmarks

TypeNameUpside
StockAvadel Pharmaceuticals190.54%
SectorHealthcare Stocks 35.25%
IndustrySpecialty & Generic Drug Manufacturers Stocks47.55%

Price Target Trends

1M3M12M
# Anlaysts--4
Avg Price Target--$24.25
Last Closing Price$8.03$8.03$8.03
Upside/Downside--201.99%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2537---10
Mar, 2537---10
Feb, 2536---9
Jan, 2537---10
Dec, 2437---10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 10, 2025Oren LivnatH.C. Wainwright$21.00$7.90165.82%161.52%
Jan 09, 2025Ami FadiaNeedham$19.00$10.8674.95%136.61%
Oct 31, 2024Francois BriseboisOppenheimer$30.00$12.91132.38%273.60%
May 09, 2024Oren LivnatH.C. Wainwright$27.00$16.2566.15%236.24%
Nov 30, 2022Jefferies$11.00$8.8524.29%36.99%
Aug 11, 2022Leerink Partners$12.00$7.1468.07%49.44%
Aug 10, 2022Needham$9.00$7.3123.12%12.08%
Aug 09, 2022Chris HowertonJefferies$8.00$7.319.44%-0.37%
May 31, 2022Needham$6.00$2.50140.00%-25.28%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 10, 2025OppenheimerOutperformOutperformhold
Jan 10, 2025H.C. WainwrightBuyBuyhold
Jan 09, 2025NeedhamBuyBuyhold
Oct 31, 2024OppenheimerOutperformOutperformhold
Oct 21, 2024H.C. WainwrightBuyBuyhold
Aug 28, 2024H.C. WainwrightBuyBuyhold
Jun 11, 2024Rodman & RenshawBuyinitialise
May 09, 2024Craig-HallumBuyBuyhold
May 09, 2024H.C. WainwrightBuyBuyhold
Mar 05, 2024OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.13$-2.00$-0.51----
Avg Forecast$-0.13$-1.79$-0.50$0.15$0.76$1.45$1.87
High Forecast$-0.12$-1.76$-0.45$0.49$1.03$1.95$1.91
Low Forecast$-0.14$-1.83$-0.53$0.03$0.49$1.27$1.81
Surprise %-200.00%11.73%2.00%----

Revenue Forecast

$0 $100M $200M $300M $400M $500M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$22.33M$27.96M$169.12M----
Avg Forecast$22.32M$26.75M$168.79M$252.17M$336.16M$406.73M$463.03M
High Forecast$23.95M$28.37M$169.03M$255.17M$338.14M$408.60M$469.81M
Low Forecast$20.96M$24.11M$168.73M$247.31M$334.19M$404.86M$451.77M
Surprise %0.08%4.55%0.19%----

Net Income Forecast

$-200M $-120M $-40M $40M $120M $200M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.03M$-160.28M$-48.83M----
Avg Forecast$-10.42M$-144.15M$-39.30M$11.63M$78.12M$149.10M$149.93M
High Forecast$-9.60M$-141.24M$-36.16M$39.36M$82.27M$156.07M$152.78M
Low Forecast$-11.41M$-147.06M$-42.44M$2.19M$39.56M$101.92M$145.19M
Surprise %-167.43%11.19%24.25%----

AVDL Forecast FAQ

Is Avadel Pharmaceuticals stock a buy?

Avadel Pharmaceuticals stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Avadel Pharmaceuticals is a favorable investment for most analysts.

What is Avadel Pharmaceuticals's price target?

Avadel Pharmaceuticals's price target, set by 12 Wall Street analysts, averages $23.33 over the next 12 months. The price target range spans from $19 at the low end to $30 at the high end, suggesting a potential 190.54% change from the previous closing price of $8.03.

How does Avadel Pharmaceuticals stock forecast compare to its benchmarks?

Avadel Pharmaceuticals's stock forecast shows a 190.54% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the specialty & generic drug manufacturers stocks industry (47.55%).

What is the breakdown of analyst ratings for Avadel Pharmaceuticals over the past three months?

  • April 2025: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Avadel Pharmaceuticals’s EPS forecast?

Avadel Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $0.15, marking a -129.41% decrease from the reported $-0.51 in 2024. Estimates for the following years are $0.76 in 2026, $1.45 in 2027, and $1.87 in 2028.

What is Avadel Pharmaceuticals’s revenue forecast?

Avadel Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $252.17M, reflecting a 49.11% increase from the reported $169.12M in 2024. The forecast for 2026 is $336.16M, followed by $406.73M for 2027, and $463.03M for 2028.

What is Avadel Pharmaceuticals’s net income forecast?

Avadel Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $11.64M, representing a -123.83% decrease from the reported $-48.832M in 2024. Projections indicate $78.12M in 2026, $149.1M in 2027, and $149.93M in 2028.